Innovative & Next Generation Biotechnology

 

Global Precision
Medicine Innovator

NGeneBio covers cancer in vitro diagnosis and companion diagnosis, bioinformatics system, disease diagnosis, liquid biopsy. We would like to contribute to the opening of the era of precision medicine through diagnostic products and services that have proven their safety and effectiveness.

Molecular
Diagnostics

Companion
Diagnostics

Bioinformatics

Personal genetic
testing service

BRCAaccuTest™

Genetic testing for
BRCA ½ mutations

LEARN MORE

HEMEaccuTest™

Genetic variants screening for
hematologic malignancies

LEARN MORE

SOLIDaccuTest™

Genetic variants screening
for solid tumors

LEARN MORE

HLAaccuTest™

Human Leukocyte Antigen Typing Kit

LEARN MORE

ONCOaccuPanel™

Comprehensive solid tumor
oncology NGS kit

LEARN MORE

Analysis Software

NGeneBio offers user-friendly and automatic analysis software to analyse the NGS sequencing data.

Automatic
Analyze

Visualization

Report

News Center

VIEW ALL
Press Center
2021-09-08

[KR] NGeneBio and CNUHH will build a cloud-based genome analysis platform

NGeneBio has signed a service contract with Chonnam National University Hwasun Hospital(CNUHH) to build a 'cloud-based genome analysis platform' to support clinical data analysis and precision medicine service development. This…
News
2021-08-27

NGeneBio at AACC 2021

NGeneBio is going to participate in AACC 2021, which will be held in Atlanta on 26-30 September at the Georgia World Congress Center. This year, the 2021 AACC Annual Scientific…
Press Center
2021-08-23

[KR] NGeneBio gained approval ‘BRCAaccuTEST PLUS’ from KFDA

NGeneBio’s genetic testing products for BRCA1 and BRCA2 mutations gained approval from Korea MFDS (Ministry of Food and Drug Safety) Following the CE-IVD registration, We are proud to share that…
Location
Contact Us
Download Center